Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy
With the development of nanomedicine technology, stimuli-responsive nanocarriers play an increasingly important role in antitumor therapy. Compared with the normal physiological environment, the tumor microenvironment (TME) possesses several unique properties, including acidity, high glutathione (GS...
Main Authors: | Weixin Zhou, Yujie Jia, Yani Liu, Yan Chen, Pengxuan Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/11/2346 |
Similar Items
-
Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
by: Reju George Thomas, et al.
Published: (2020-12-01) -
Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
by: Reju George Thomas, et al.
Published: (2021-05-01) -
Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
by: Jia R, et al.
Published: (2021-02-01) -
Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy
by: Su Yuanzhen, et al.
Published: (2023-02-01) -
Stimuli-responsive polyprodrug for cancer therapy
by: C. Lin, et al.
Published: (2022-08-01)